Literature DB >> 27117662

Tumor-Derived Exosomes and Their Role in Cancer Progression.

Theresa L Whiteside1.   

Abstract

Tumor cells actively produce, release, and utilize exosomes to promote tumor growth. Mechanisms through which tumor-derived exosomes subserve the tumor are under intense investigation. These exosomes are information carriers, conveying molecular and genetic messages from tumor cells to normal or other abnormal cells residing at close or distant sites. Tumor-derived exosomes are found in all body fluids. Upon contact with target cells, they alter phenotypic and functional attributes of recipients, reprogramming them into active contributors to angiogenesis, thrombosis, metastasis, and immunosuppression. Exosomes produced by tumors carry cargos that in part mimic contents of parent cells and are of potential interest as noninvasive biomarkers of cancer. Their role in inhibiting the host antitumor responses and in mediating drug resistance is important for cancer therapy. Tumor-derived exosomes may interfere with cancer immunotherapy, but they also could serve as adjuvants and antigenic components of antitumor vaccines. Their biological roles in cancer development or progression as well as cancer therapy suggest that tumor-derived exosomes are critical components of oncogenic transformation.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer progression; Exosome content; Exosomes; Exosomes in immunoregulation; Information transfer; Tumor microenvironment; Tumor-derived exosomes

Mesh:

Substances:

Year:  2016        PMID: 27117662      PMCID: PMC5382933          DOI: 10.1016/bs.acc.2015.12.005

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  147 in total

1.  Mechanisms of T-cell protection from death by IRX-2: a new immunotherapeutic.

Authors:  Malgorzata Czystowska; Miroslaw J Szczepanski; Marta Szajnik; Karen Quadrini; Harvey Brandwein; John W Hadden; Theresa L Whiteside
Journal:  Cancer Immunol Immunother       Date:  2010-12-23       Impact factor: 6.968

Review 2.  Extracellular vesicles--vehicles that spread cancer genes.

Authors:  Janusz Rak; Abhijit Guha
Journal:  Bioessays       Date:  2012-03-22       Impact factor: 4.345

3.  Multisite comparison of high-sensitivity multiplex cytokine assays.

Authors:  Elizabeth Crabb Breen; Sandra M Reynolds; Christopher Cox; Lisa P Jacobson; Larry Magpantay; Candice B Mulder; Oliver Dibben; Joseph B Margolick; Jay H Bream; Elise Sambrano; Otoniel Martínez-Maza; Elizabeth Sinclair; Persephone Borrow; Alan L Landay; Charles R Rinaldo; Philip J Norris
Journal:  Clin Vaccine Immunol       Date:  2011-06-22

4.  Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.

Authors:  Jeong Whun Kim; Eva Wieckowski; Douglas D Taylor; Torsten E Reichert; Simon Watkins; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2005-02-01       Impact factor: 12.531

5.  Survivin is released from cancer cells via exosomes.

Authors:  Salma Khan; Jessica M S Jutzy; Jonathan R Aspe; Dalmor W McGregor; Jonathan W Neidigh; Nathan R Wall
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

6.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

Review 7.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

Review 8.  Therapeutic potential of targeting interleukin 5 in asthma.

Authors:  Garry M Walsh
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

Review 9.  Exosomes in cancer: small particle, big player.

Authors:  Xu Zhang; Xiao Yuan; Hui Shi; Lijun Wu; Hui Qian; Wenrong Xu
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388

10.  Exosomal HIF1α supports invasive potential of nasopharyngeal carcinoma-associated LMP1-positive exosomes.

Authors:  M Aga; G L Bentz; S Raffa; M R Torrisi; S Kondo; N Wakisaka; T Yoshizaki; J S Pagano; J Shackelford
Journal:  Oncogene       Date:  2014-03-24       Impact factor: 9.867

View more
  224 in total

1.  Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer.

Authors:  Sonja Ludwig; Theofanis Floros; Marie-Nicole Theodoraki; Chang-Sook Hong; Edwin K Jackson; Stephan Lang; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2017-04-11       Impact factor: 12.531

Review 2.  Extracellular membrane vesicles in the three domains of life and beyond.

Authors:  Sukhvinder Gill; Ryan Catchpole; Patrick Forterre
Journal:  FEMS Microbiol Rev       Date:  2019-05-01       Impact factor: 16.408

3.  Mining Exosomal Genes for Pancreatic Cancer Targets.

Authors:  Amy Makler; Ramaswamy Narayanan
Journal:  Cancer Genomics Proteomics       Date:  2017 May-Jun       Impact factor: 4.069

4.  Comparison of an Optimized Ultracentrifugation Method versus Size-Exclusion Chromatography for Isolation of Exosomes from Human Serum.

Authors:  Mingrui An; Jing Wu; Jianhui Zhu; David M Lubman
Journal:  J Proteome Res       Date:  2018-09-19       Impact factor: 4.466

Review 5.  Antitumour dendritic cell vaccination in a priming and boosting approach.

Authors:  Alexandre Harari; Michele Graciotti; Michal Bassani-Sternberg; Lana E Kandalaft
Journal:  Nat Rev Drug Discov       Date:  2020-08-06       Impact factor: 84.694

6.  Circulating Microvesicles from Pancreatic Cancer Accelerate the Migration and Proliferation of PANC-1 Cells.

Authors:  Mingrui An; Jianhui Zhu; Jing Wu; Kyle C Cuneo; David M Lubman
Journal:  J Proteome Res       Date:  2018-03-09       Impact factor: 4.466

Review 7.  Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.

Authors:  Suzanne Ostrand-Rosenberg; Catherine Fenselau
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

8.  Separation of plasma-derived exosomes into CD3(+) and CD3(-) fractions allows for association of immune cell and tumour cell markers with disease activity in HNSCC patients.

Authors:  M-N Theodoraki; T K Hoffmann; T L Whiteside
Journal:  Clin Exp Immunol       Date:  2018-03-12       Impact factor: 4.330

9.  Impact of circulating tumor DNA early detection and serial monitoring in the management of stage I to III colorectal cancer.

Authors:  Diana Bello Roufai; François-Clément Bidard
Journal:  Ann Transl Med       Date:  2019-12

Review 10.  Exosomes: nanodust?

Authors:  L Muller
Journal:  HNO       Date:  2020-01       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.